09/04/2024 7:03 PM | Abbott Laboratories (Issuer) Boudreau Philip P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 6:52 PM | Abbott Laboratories (Issuer) MCCOY JOHN A. JR. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 3:02 PM | Abbott Laboratories (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024 6:37 AM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 3:39 PM | Abbott Laboratories (Issuer) Morrone Louis H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 3:30 PM | Abbott Laboratories (Issuer) Roman Michael F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 4:35 PM | Abbott Laboratories (Issuer) Funck, Jr. Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/07/2024 5:59 PM | Abbott Laboratories (Subject) Earnhardt Lisa D (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024 3:02 PM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 5:05 PM | Abbott Laboratories (Issuer) McKinstry Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 5:11 PM | Abbott Laboratories (Issuer) O'Grady Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 5:16 PM | Abbott Laboratories (Issuer) Roman Michael F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 5:22 PM | Abbott Laboratories (Issuer) STARKS DANIEL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 5:29 PM | Abbott Laboratories (Issuer) Stratton John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 4:54 PM | Abbott Laboratories (Issuer) Kumbier Michelle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 5:00 PM | Abbott Laboratories (Issuer) McDew Darren W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 4:43 PM | Abbott Laboratories (Issuer) Blount Sally E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 4:48 PM | Abbott Laboratories (Issuer) Gonzalez Patricia Paola (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 4:33 PM | Abbott Laboratories (Issuer) Alpern Robert J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 4:38 PM | Abbott Laboratories (Issuer) Babineaux-Fontenot Claire (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 6:36 AM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 5:50 PM | Abbott Laboratories (Issuer) Roman Michael F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 5:58 PM | Abbott Laboratories (Issuer) Stratton John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 5:32 PM | Abbott Laboratories (Issuer) Alpern Robert J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 5:40 PM | Abbott Laboratories (Issuer) Gonzalez Patricia Paola (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:09 PM | Abbott Laboratories (Issuer) Moreland Mary K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:14 PM | Abbott Laboratories (Issuer) Morrone Louis H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:18 PM | Abbott Laboratories (Issuer) Salvadori Daniel Gesua Sive (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:22 PM | Abbott Laboratories (Issuer) Wainer Andrea F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:56 PM | Abbott Laboratories (Issuer) Ford Robert B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:00 PM | Abbott Laboratories (Issuer) Funck, Jr. Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:05 PM | Abbott Laboratories (Issuer) MCCOY JOHN A. JR. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:39 PM | Abbott Laboratories (Issuer) ALLEN HUBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:44 PM | Abbott Laboratories (Issuer) Boudreau Philip P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:50 PM | Abbott Laboratories (Issuer) Earnhardt Lisa D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:53 PM | Abbott Laboratories (Subject) Salvadori Daniel Gesua Sive (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:39 PM | Abbott Laboratories (Subject) Moreland Mary K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:45 PM | Abbott Laboratories (Subject) Morrone Louis H. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:22 PM | Abbott Laboratories (Subject) ALLEN HUBERT L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:25 PM | Abbott Laboratories (Subject) Earnhardt Lisa D (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:32 PM | Abbott Laboratories (Subject) MCCOY JOHN A. JR. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
NASDAQ to crash 50%? (Ad) During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out...
Now, he's saying there are four major cracks forming in the US economy...![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9492&Placement=NativeDisplay&Source=NativeDisplay) Click here to learn more >>> |
02/27/2024 5:13 PM | Abbott Laboratories (Issuer) Wainer Andrea F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:45 PM | Abbott Laboratories (Issuer) Wainer Andrea F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:35 PM | Abbott Laboratories (Issuer) MCCOY JOHN A. JR. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:38 PM | Abbott Laboratories (Issuer) Moreland Mary K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:40 PM | Abbott Laboratories (Issuer) Morrone Louis H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:43 PM | Abbott Laboratories (Issuer) Salvadori Daniel Gesua Sive (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:27 PM | Abbott Laboratories (Issuer) Ford Robert B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:29 PM | Abbott Laboratories (Issuer) Funck, Jr. Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:33 PM | Abbott Laboratories (Issuer) Earnhardt Lisa D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:23 PM | Abbott Laboratories (Issuer) Boudreau Philip P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:03 PM | Abbott Laboratories (Issuer) ALLEN HUBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:15 PM | Abbott Laboratories (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
01/31/2024 4:30 PM | Abbott Laboratories (Issuer) Wainer Andrea F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 3:04 PM | Abbott Laboratories (Subject) Wainer Andrea F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024 6:36 AM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 4:38 PM | Abbott Laboratories (Issuer) Stratton John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:28 PM | Abbott Laboratories (Issuer) Alpern Robert J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:30 PM | Abbott Laboratories (Issuer) Gonzalez Patricia Paola (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:33 PM | Abbott Laboratories (Issuer) Roman Michael F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 4:36 PM | Abbott Laboratories (Issuer) Wainer Andrea F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 6:37 AM | Abbott Laboratories (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 5:45 PM | Abbott Laboratories (Issuer) Alpern Robert J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 5:46 PM | Abbott Laboratories (Issuer) Gonzalez Patricia Paola (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 5:48 PM | Abbott Laboratories (Issuer) Roman Michael F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 5:49 PM | Abbott Laboratories (Issuer) Stratton John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 4:35 PM | Abbott Laboratories (Issuer) Funck, Jr. Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |